# ðŸ’Ž Strategic Funding Proposal: DFG Reinhart Koselleck-Projekt

**Project Title:** *Semantic Volumetrics: Foundation Models for the Longitudinal Digital Twin in Coronary Artery Disease*

**Principal Investigator (Target):** Prof. Marc Dewey  
**Institution:** CharitÃ© â€“ UniversitÃ¤tsmedizin Berlin, Department of Radiology  
**Funding Mechanism:** DFG Reinhart Koselleck-Projekt  
**Requested Duration:** 5 years  
**Estimated Budget:** â‚¬1.5-2.0M

---

## Executive Summary: Transforming Cardiovascular Care Through AI

**The Clinical Problem**: Manual coronary segmentation is a bottleneck preventing precision cardiovascular medicine:
- **Patients wait weeks** for core-lab analysis results (delays treatment decisions)
- **Costs â‚¬200-400 per case** (limits access to advanced imaging analysis)
- **Only available at specialized centers** (excludes rural/resource-limited hospitals)
- **Cannot scale to population-level screening** (millions of chest pain patients annually)

<<<<<<< HEAD
**The Human Impact**: 
- Delayed diagnosis â†’ continued angina, preventable MACE
- High costs â†’ rationing of advanced imaging analysis
- Limited access â†’ health disparities between urban/rural populations
- Slow research â†’ years to analyze trial data, delaying clinical translation
=======
**The Core Innovation:** Adapting Meta's Segment Anything Model (SAM) to 3D cardiovascular and oncological imaging, creating the first **multi-domain foundation model** trained on unprecedented scale: DISCHARGE (25M images), SCOT-HEART (10M images), and Prostate Trial (4M images).
>>>>>>> 3259bc51afe7eefab41a302d45af8337b4c42427

**Our Solution**: Browser-based AI segmentation platform where:
- **Clinicians click on coronary artery â†’ AI segments it in 2 seconds** (vs. 30-60 minutes manual)
- **Works in any browser** (no software installation, accessible from clinic/home)
- **AI runs on hospital server** (data stays secure, GDPR compliant)
- **10x faster, â‚¬20-40 per case** (vs. â‚¬200-400 manual)

**Patient Benefits**:
- **Faster diagnosis**: Results same day (vs. weeks waiting for core-lab)
- **Better access**: Available at any hospital with CT scanner (not just specialized centers)
- **Lower costs**: â‚¬180-360 savings per patient â†’ more patients can access advanced imaging
- **Earlier intervention**: Rapid plaque characterization â†’ timely treatment â†’ prevent MACE

**Healthcare System Benefits**:
- **â‚¬1.8-3.6 million annual savings** per hospital (1,000 cases/year)
- **Democratize advanced imaging**: Enable precision cardiology at community hospitals
- **Accelerate research**: Analyze trial data in months (vs. years) â†’ faster clinical translation
- **Reduce health disparities**: Make expert-level analysis accessible to underserved populations

**The Innovation** (Reinhart Koselleck criteria):
- **Exceptionally innovative**: First browser-based foundation model platform for cardiovascular imaging
- **High risk**: Can SAM (trained on natural images) achieve clinical-grade accuracy on medical images?
- **High reward**: Transform cardiovascular care globallyâ€”from specialized centers to every hospital

**Technology**: TypeScript + Vite + Niivue (browser) + FastAPI + SAM-Med3D (hospital server)

---

## 1. Why Reinhart Koselleck?

### The "Exceptionally Innovative" Criterion
Traditional AI in radiology is **static**â€”focused on **detection** (finding lesions). We propose to build a model that understands the **evolution of disease**â€”moving from detection to **prediction** (understanding which lesions will cause events). This requires:
- Training on outcome data (MACE from DISCHARGE)â€”the model won't just see "a plaque"; it will see "a plaque that likely leads to an event"
- Longitudinal modeling (plaque progression over time)
- Foundation model adaptation (SAM â†’ cardiovascular domain via plaque-aware adapter)
- Fine-tuning on existing high-quality ground truth masks to bridge the gap between "General SAM" and "Clinical-Grade SAM"

### The "High-Risk" Criterion
**Three Major Uncertainties:**

1. **Multi-Vendor Harmonization Challenge**
   - DISCHARGE/SCOT-HEART span Siemens, GE, Canon scanners
   - Contrast protocols vary significantly
   - **The Risk:** Can a single model achieve consistent plaque quantification that matches (and eventually exceeds) core-lab standards across this heterogeneity?

2. **Foundation Model Transferability**
   - SAM was trained on natural images (SA-1B dataset)
   - Medical imaging has fundamentally different statistics (low contrast, noise, motion artifacts)
   - **The Risk:** Can a Foundation Model be adapted to identify "vulnerable" plaque features (low-attenuation, positive remodeling) with the same reliability as a trained sub-specialist?

3. **Clinical Validation Gap**
   - Core-lab experts require years of training
   - **The Risk:** Can AI match their inter-observer agreement (Îº~0.7-0.8) in identifying high-risk plaque?
   - Will radiologists trust AI for high-stakes decisions involving patient management?

---

## 2. Scientific Foundation

### 2.1 The Data Goldmine

#### DISCHARGE Trial (25M images)
- **Design:** Multicenter RCT comparing CCTA vs. invasive angiography
- **Scale:** ~3,500 patients, ~25 million image slices
- **Outcome Data:** 3.5-year MACE follow-up
- **Our Advantage:** Link plaque morphology â†’ clinical events at unprecedented scale
- **Status:** Data access via Prof. Dewey (trial steering committee)

#### SCOT-HEART Trial (10M images)
- **Design:** CCTA vs. standard care for stable chest pain
- **Scale:** ~4,100 patients, ~10 million image slices
- **Outcome Data:** 5-year MACE, 10-year mortality
- **Our Advantage:** External validation, different population (UK vs. EU)
- **Status:** Collaboration established with University of Edinburgh

#### Prostate Trial (4M images)
- **Design:** Multi-parametric MRI for prostate cancer detection
- **Scale:** ~4 million image slices across multiple sequences (T2W, DWI, DCE)
- **Cross-Domain Impact:** Validates foundation model generalization beyond cardiovascular
- **Our Advantage:** Tests SAM adapter on different tissue types, contrast mechanisms
- **Status:** Data access negotiations in progress
- **Technical Validation:** Leverage existing MRI classification pipeline (boahK/MRI_Classifier)
  - Pre-trained models for multi-parametric body MRI series classification
  - Confusion matrix validation framework
  - Siemens/Philips multi-vendor training strategy (Strategy 2 approach)

#### Utilizing the Annotation Goldmine
- **Existing high-quality ground truth segmentations** from prior core-lab work (DISCHARGE + SCOT-HEART)
- Enables supervised fine-tuning of Mask SAM 3D adapter on domain-specific features
- Bridges the critical gap between "General SAM" (natural images) and "Clinical-Grade SAM" (medical imaging)
- Foundation for active learning loop: AI suggests â†’ Human corrects â†’ Model improves

### 2.2 Technical Innovation: Mask SAM 3D Architecture

**Dual-Stage Pipeline:**

**Stage 1: nnU-Net Prior**
- Generates coarse arterial skeleton
- Provides anatomical context (which vessel is which)
- Reduces search space for SAM

**Stage 2: SAM-3D Adapter ("Plaque-Aware Refinement")**
- Takes nnU-Net mask as semantic prompt
- Refines segmentation with plaque-specific attention mechanisms
- Outputs:
  - Vessel lumen boundary
  - Plaque composition (calcified, non-calcified, low-attenuation)
  - Remodeling index
  - Stenosis severity

**Why This Hybrid Matters:**
- **Standard nnU-Net limitation:** Misses subtle plaques due to low contrast
- **Pure SAM limitation:** Lacks cardiovascular anatomical priors
- **Our solution:** Hybrid approach where nnU-Net provides anatomical context and SAM-3D refines with plaque-specific intelligence
- **Critical advantage:** Can identify high-risk plaques that standard models miss

---

## 3. Research Objectives

### Primary Aim
Develop and validate a foundation model for automated plaque characterization that matches core-lab expert performance in predicting MACE.

### Secondary Aims

**Aim 1: Technical Development**
- Adapt SAM architecture to 3D medical imaging
- Train plaque-aware adapter on DISCHARGE annotations
- Optimize for multi-vendor generalization

**Aim 2: Clinical Validation**
- Compare AI vs. expert segmentations (Dice, Hausdorff distance)
- Assess MACE prediction accuracy (AUC, hazard ratios)
- Validate on SCOT-HEART (external cohort)

**Aim 3: Longitudinal Modeling**
- Track plaque progression in serial scans
- Identify features predictive of rapid progression
- Build "digital twin" framework for patient-specific risk

**Aim 4: Knowledge Transfer ("Refine-as-You-Go")**
- Deploy interactive annotation platform (Niivue-based WebGL2 interface)
- Enable collaborative refinement by research team via browser-based interface
- **Active Learning Loop:** AI suggests â†’ Human corrects â†’ Model improves iteratively
- Zero-installation deployment on CharitÃ© GPU cluster with secure VPN access
- Build the "interface through which the next decade of cardiovascular trials will be analyzed"

---

## 4. Methodology

### 4.1 Technical Architecture: Browser-Based Clinical Platform

**Core Innovation**: Zero-installation browser interface + hospital-deployed AI backend

#### Frontend: TypeScript + Vite + Niivue (Latest)

**Technology Stack** (based on proven `frac` project, upgraded):
```typescript
// package.json dependencies
{
  "@niivue/niivue": "latest",        // WebGL2 3D visualization
  "@niivue/dcm2niix": "^1.2.0",      // DICOM conversion in-browser
  "@niivue/itkwasm-loader": "latest", // DICOM series loading
  "@kitware/vtk.js": "latest",       // Mesh generation (marching cubes)
  "typescript": "^5.6.0",             // Type safety
  "vite": "^7.0.0"                    // Build system
}
```

**Deployment Options**:
1. **Browser-Based** (Primary): Zero-installation web app via HTTPS
2. **Tauri Desktop App** (Alternative): Cross-platform native app for offline use
   - Windows/macOS/Linux support
   - Local GPU acceleration
   - Ideal for sites without reliable internet

**Project Structure**:
```
flow-segment-frontend/
â”œâ”€â”€ src/
â”‚   â”œâ”€â”€ main.ts                 # Application entry
â”‚   â”œâ”€â”€ components/
â”‚   â”‚   â”œâ”€â”€ Viewer.ts           # Niivue wrapper
â”‚   â”‚   â”œâ”€â”€ SegmentPanel.ts     # AI segmentation UI
â”‚   â”‚   â””â”€â”€ ResultsPanel.ts     # Display results
â”‚   â”œâ”€â”€ services/
â”‚   â”‚   â”œâ”€â”€ api.ts              # Backend API client
â”‚   â”‚   â””â”€â”€ niivue.ts           # Niivue initialization
â”‚   â””â”€â”€ types/
â”‚       â”œâ”€â”€ volume.ts           # Volume data types
â”‚       â””â”€â”€ segmentation.ts     # Segmentation types
â”œâ”€â”€ vite.config.ts
â””â”€â”€ tsconfig.json
```

**Key capabilities** (from Niivue + vtk.js):
- **WebGL2 rendering** for 3D CCTA visualization
- **Interactive click-to-segment** (capture 3D coordinates)
- **Multi-planar reconstruction (MPR)** with curved reformats
- **Mesh overlay rendering** (for AI segmentation results)
- **Surface mesh generation** via vtk.js ImageMarchingCubes:
  - Convert binary masks â†’ 3D surface meshes in-browser
  - Alternative: nii2mesh (ITK-WASM) for high-quality decimated meshes
  - Point cloud â†’ mesh conversion for coronary artery surfaces
- **DICOM processing**:
  - dcm2niix for DICOM â†’ NIfTI conversion
  - ITK-WASM loader for multi-series DICOM loading
- **4D volume support** (for perfusion imaging)

**3D Mesh Visualization & Generation**:
- **Point cloud â†’ surface mesh**: Direct NVMesh construction from coronary artery point clouds
  - Input: vertices (Float32Array) + triangle indices (Uint32Array) in mm coordinates
  - Overlay coronary surface meshes on CT base layer
  - Example: `nv.addMesh(new NVMesh(pts, tris, 'coronary', rgba, opacity, visible, gl))`
- **Mask volume â†’ surface mesh**: Two pathways
  - **Browser-based**: vtk.js ImageMarchingCubes for in-browser marching cubes
  - **Server-based**: nii2mesh (ITK-WASM) for high-quality decimated meshes
- **Connectome visualization**: 3D line overlays for vessel centerlines
  - Nodes (x,y,z in mm) + edges â†’ closed loop rendering
  - Useful for displaying vessel paths and cross-sectional contours

#### Backend: FastAPI + SAM-Med3D + Image Processing Pipeline

**Model**: SAM-Med3D-turbo (uni-medical/SAM-Med3D)
- Pre-trained on 44 medical imaging datasets
- Point/box prompting support
- PyTorch 2.6.0 implementation
- Available on Hugging Face

**API Architecture**:
```python
# FastAPI endpoints
POST /api/segment/point       # Point-based prompting
POST /api/segment/box         # Bounding box prompting
POST /api/volumes/upload      # DICOM/NIfTI upload
POST /api/mesh/generate       # Mask â†’ mesh conversion (nii2mesh)
POST /api/register/longitudinal # Image registration (Elastix)
GET  /api/volumes/{id}        # Retrieve volume
GET  /api/health              # Health check
```

**Image Processing Tools** (Python backend):
- **Elastix** (elastix.wasm.itk.eth.limo): Deformable registration for longitudinal tracking
- **nii2mesh** (ITK-WASM): High-quality surface mesh generation with decimation
- **SimpleITK**: Additional preprocessing and resampling utilities

**Deployment**: Docker container on CharitÃ© GPU cluster
- NVIDIA A100/V100 GPUs
- Redis cache for feature embeddings (sub-second response)
- PACS integration for DICOM ingestion
- VPN + HTTPS for secure access

### 4.2 Model Development (Adapted from SAM-Med3D)

**Phase 1: Foundation Model Adaptation (Months 1-12)**
- Download SAM-Med3D-turbo pre-trained weights
- Fine-tune on DISCHARGE coronary annotations (~300 cases)
- Implement nnU-Net â†’ SAM-Med3D integration pipeline
- **Deliverable**: Coronary-specific SAM adapter

**Phase 2: Browser Platform Development (Months 1-12, parallel)**
- Build TypeScript + Vite + Niivue frontend
- Implement FastAPI backend with SAM-Med3D
- Deploy to CharitÃ© infrastructure
- **Deliverable**: Interactive segmentation platform

**Phase 3: Multi-Vendor Optimization (Months 13-24)**
- Test on Siemens, GE, Canon scanners (DISCHARGE multi-vendor)
- Develop normalization strategies per vendor
- Benchmark on held-out test sets
- **Deliverable**: Vendor-agnostic model

**Phase 4: Clinical Validation (Months 25-36)**
- Compare AI vs. expert segmentations (100 cases, 3 readers)
- Validate on SCOT-HEART (external cohort, n=4,100)
- MACE prediction analysis
- **Cross-domain validation**: Apply to prostate MRI dataset
  - Test generalization to non-cardiovascular imaging
  - Leverage MRI_Classifier framework for multi-sequence handling
- **Deliverable**: Clinical validation manuscript

**Phase 5: Longitudinal Extension (Months 37-48)**
- Implement temporal registration for serial scans:
  - **Elastix** for deformable registration (elastix.wasm.itk.eth.limo)
  - Handle multi-timepoint alignment despite cardiac motion
  - Track individual plaque progression across follow-up scans
- Train progression prediction model
- Build digital twin framework
- **Deliverable**: Longitudinal modeling manuscript

### 4.3 Implementation Roadmap (Integrated from Technical Plan)

#### Phase 1: Minimal Viable Research (MVR) Tool (Months 1-3)

**Backend Setup**:
- Containerize SAM-Med3D-turbo (Docker + PyTorch 2.6)
- Implement FastAPI endpoints (segment/point, segment/box, volumes/upload)
- Set up embedding cache (Redis) for <2s response time
- Test with single DISCHARGE volume

**Frontend Development**:
- Initialize Vite + TypeScript project
- Install @niivue/niivue (latest stable)
- Implement core features:
  - Volume loading (NIfTI format)
  - Click event capture â†’ 3D coordinate extraction
  - API integration for segmentation requests
  - Overlay rendering with toggle controls
- Add MPR view synchronization

**Integration & Testing**:
- Connect frontend â†” backend via REST API
- Test interactive loop:
  1. Load DISCHARGE CCTA volume in Niivue
  2. User clicks coronary artery point
  3. Backend returns 3D segmentation mask
  4. Niivue overlays mask in real-time
- Optimize latency (target: <2s per segmentation)

**Milestone 1**: Working prototype with single-case demo

#### Phase 2: Clinical Deployment at CharitÃ© (Months 4-6)

**Infrastructure**:
- Deploy on CharitÃ© GPU cluster (NVIDIA A100)
- Implement authentication (LDAP/SSO integration)
- Set up secure DICOM ingestion pipeline
- Configure HTTPS + VPN access

**Active Learning Workflow**:
- Add annotation refinement tools in Niivue:
  - Brush tool for mask correction
  - Eraser for false positives
  - Save corrected masks to training database
- Implement feedback loop:
  - Collect user corrections
  - Periodic model fine-tuning on refined annotations
  - Version control for model iterations

**SCOT-HEART Integration**:
- Batch process SCOT-HEART dataset (n=4,100)
- Generate initial segmentations for review
- Enable collaborative annotation by research team
- Quality control dashboard (Dice scores, manual review flags)

**Milestone 2**: Platform deployed, team onboarded, batch processing operational

#### Phase 3: Clinical Validation (Months 7-12)

**Validation Strategy**:
1. **Internal Validation:** 80/20 train/test split on DISCHARGE
2. **External Validation:** Full SCOT-HEART dataset (no training)
3. **Expert Comparison:** 100 cases independently read by 3 core-lab experts

**Metrics**:
- **Segmentation:** Dice coefficient >0.85, Hausdorff distance <2mm
- **Classification:** Sensitivity/specificity for high-risk plaque
- **Prediction:** AUC for MACE, net reclassification improvement (NRI)
- **Efficiency:** Time savings vs. manual segmentation (target: 10x faster)

**Milestone 3**: Validation complete, first manuscript submitted

### 4.4 Deployment Strategy: Hospital-Based Platform

**Deployment Model**: On-premise at CharitÃ© (GDPR compliant)

**Architecture**:
```
[Clinician Browser/Tauri App] â†HTTPS/VPNâ†’ [CharitÃ© Firewall] â†’ [Frontend: Nginx] 
                                                                       â†“
                                                      [Backend: FastAPI + SAM-Med3D]
                                                                       â†“
                                                           [Processing Pipeline]
                                                           - Elastix (registration)
                                                           - nii2mesh (surface gen)
                                                           - dcm2niix (conversion)
                                                                       â†“
                                                      [GPU Cluster: NVIDIA A100]
                                                                       â†“
                                                           [PACS Integration]
```

**Deployment Flexibility**:
- **Primary**: Browser-based (zero installation, works on any device)
- **Alternative**: Tauri desktop app for:
  - Sites with limited internet bandwidth
  - Offline processing scenarios
  - Users preferring native app experience
  - Cross-platform: Windows, macOS, Linux

**Security & Compliance**:
- No external data transfer (all processing on-premise)
- LDAP/SSO authentication
- Audit logging for all segmentations
- GDPR Article 32 compliance (data security)
- EU AI Act Article 14 compliance (human oversight)

**Scalability**:
- Single server supports 10-20 concurrent users
- Batch processing overnight (100+ cases)
- Multi-site deployment (CharitÃ© â†’ other hospitals)

**Active Learning Loop**:
- AI suggests segmentations
- Experts correct via intuitive Niivue interface
- Model retrains weekly on corrected data
- Performance improves iteratively (continuous learning)

---

## 5. Work Plan & Milestones

### Year 1: Foundation
- **Q1-Q2:** Infrastructure setup, multi-trial data ingestion (39M images total), baseline nnU-Net training
- **Q3-Q4:** SAM adapter development, initial DISCHARGE experiments (25M images)
- **Milestone:** Proof-of-concept across all three domains (cardiovascular + prostate)

### Year 2: Optimization
- **Q1-Q2:** Multi-vendor harmonization across DISCHARGE/SCOT-HEART (35M images), hyperparameter tuning
- **Q3-Q4:** Niivue platform deployment for all datasets, team onboarding
- **Milestone:** Internal validation complete (Dice >0.85 cardiovascular, >0.80 prostate)

### Year 3: Validation
- **Q1-Q2:** SCOT-HEART external validation (10M images), prostate cross-domain validation (4M images)
- **Q3-Q4:** Expert comparison study, MACE prediction analysis across trials
- **Milestone:** First manuscript submission (technical methods + cross-domain results)

### Year 4: Longitudinal Modeling
- **Q1-Q2:** Temporal registration, progression tracking
- **Q3-Q4:** Digital twin framework, risk stratification
- **Milestone:** Second manuscript (clinical validation)

### Year 5: Translation
- **Q1-Q2:** Multi-center deployment pilot
- **Q3-Q4:** Regulatory pathway exploration (CE marking)
- **Milestone:** Final synthesis paper, commercialization plan

---

## 6. Team & Resources

### Core Team (To Be Assembled)
- **PI:** Prof. Marc Dewey (Radiology, CCTA expertise)
- **Co-PI:** AI/ML expert (computer vision, foundation models)
- **Postdoc 1:** Medical imaging AI (model development)
- **Postdoc 2:** Clinical validation (outcomes research)
- **PhD Student 1:** Technical implementation (Niivue platform)
- **PhD Student 2:** Longitudinal modeling (digital twin)
- **Research Assistant:** Data management, annotation coordination

### Infrastructure Requirements
- **Compute:** GPU cluster (4x NVIDIA A100, 80GB VRAM each)
- **Storage:** 100TB NAS for DICOM/NIfTI volumes
- **Software:** PyTorch, FastAPI, Niivue, Docker
- **Clinical:** Secure PACS integration, VPN access

### Budget Estimate (5 Years)
- **Personnel:** â‚¬1.2M (4 postdocs/PhDs, 1 RA)
- **Equipment:** â‚¬300K (GPU cluster, storage)
- **Operations:** â‚¬200K (cloud compute, conferences, publications)
- **Indirect Costs:** â‚¬300K
- **Total:** â‚¬2.0M

---

## 7. Expected Impact

### Scientific Impact
- **Paradigm Shift:** From static detection to dynamic prediction
- **Methodological Innovation:** First cardiovascular foundation model
- **Open Science:** Code, models, and annotations publicly released

### Clinical Impact
- **Efficiency:** 10x faster than manual core-lab analysis
- **Scalability:** Enable large-scale phenotyping studies
- **Precision Medicine:** Patient-specific risk stratification

### Economic Impact
- **Cost Reduction:** Reduce need for invasive angiography
- **Trial Efficiency:** Accelerate endpoint adjudication in RCTs
- **Commercialization:** Spin-off potential for clinical deployment

---

## 8. Risk Mitigation & Contingencies

### Technical Risks
| Risk | Probability | Mitigation |
|------|------------|-----------|
| SAM doesn't transfer to medical imaging | Medium | Fall back to pure nnU-Net with attention mechanisms |
| Multi-vendor harmonization fails | Low | Vendor-specific models as backup |
| Computational requirements exceed budget | Medium | Cloud compute credits, phased GPU acquisition |

### Clinical Risks
| Risk | Probability | Mitigation |
|------|------------|-----------|
| AI doesn't match expert performance | Medium | Focus on augmentation (AI + human) rather than replacement |
| Regulatory barriers to deployment | High | Engage early with notified bodies, plan CE marking pathway |
| Adoption resistance from radiologists | Medium | Co-design with end users, emphasize time savings |

---

## 9. Why Prof. Marc Dewey?

### Unique Positioning
- **Data Access:** Steering committee for DISCHARGE, collaborator on SCOT-HEART
- **Clinical Expertise:** World-leading CCTA researcher (>400 publications, h-index 89)
- **Infrastructure:** CharitÃ© has GPU cluster, PACS integration, regulatory support
- **Track Record:** Proven ability to lead large multicenter trials

### Strategic Alignment
- CharitÃ©'s focus on translational AI in radiology
- Berlin as hub for medical AI startups (regulatory sandbox)
- DFG priority on high-risk/high-reward cardiovascular research

---

## 10. Competitive Landscape

### Current State-of-the-Art
- **Commercial:** HeartFlow (FFR-CT), Cleerly (plaque analysis)
  - *Limitation:* Proprietary, black-box, expensive
- **Academic:** nnU-Net-based segmentation
  - *Limitation:* Requires extensive training data, poor generalization

### Our Differentiators
1. **Foundation Model Approach:** Leverage pre-trained SAM representations
2. **Outcome-Driven Training:** Learn from MACE data, not just morphology
3. **Open Platform:** Niivue-based interface for community adoption
4. **Longitudinal Focus:** Digital twin for progression tracking

---

## 11. Dissemination & Open Science

### Publications (Target)
- **Year 3:** Technical methods paper (Nature Methods / Medical Image Analysis)
- **Year 4:** Clinical validation (JACC: Cardiovascular Imaging / Radiology)
- **Year 5:** Longitudinal modeling (European Heart Journal / Circulation)

### Code & Data Release
- **GitHub:** Open-source Mask SAM 3D implementation
- **Zenodo:** Pre-trained model weights
- **Grand Challenge:** Public benchmark dataset (anonymized subset)

### Community Engagement
- **Workshops:** MICCAI, RSNA, ESC Congress
- **Tutorials:** Niivue platform training for researchers
- **Collaborations:** Invite external validation on other cohorts

---

## 12. Sustainability Beyond Funding

### Academic Pathway
- Establish CharitÃ© as center of excellence for cardiovascular AI
- Train next generation of medical imaging researchers
- Secure follow-on funding (ERC, Horizon Europe)

### Clinical Translation
- CE marking for clinical deployment in EU
- Licensing agreements with PACS vendors
- Integration into CharitÃ© clinical workflow

### Commercial Pathway
- Spin-off company for global distribution
- Partnerships with scanner manufacturers (Siemens, GE, Canon)
- Subscription model for cloud-based analysis

---

## 13. Conclusion: The Koselleck Vision

This proposal embodies the Reinhart Koselleck spirit:
- **Exceptional Innovation:** First foundation model for cardiovascular imaging
- **High Risk:** Uncertain if SAM transfers to medical domain
- **High Reward:** Transform cardiovascular risk assessment globally

We are not building another segmentation tool. We are building the **intelligence layer** through which the next decade of cardiovascular trials will be analyzedâ€”moving from detection to prediction, from static snapshots to dynamic digital twins.

**The Question:** Can we teach a machine to see what cardiologists seeâ€”and predict what they cannot?

**The Answer:** With DISCHARGE, SCOT-HEART, and the Mask SAM 3D architecture, we have the data, the technology, and the team to find out.

---

## Appendices

### Appendix A: Letters of Support (To Be Obtained)
- Prof. Marc Dewey (CharitÃ©)
- Prof. David Newby (University of Edinburgh, SCOT-HEART PI)
- Industry partner (Siemens Healthineers / NVIDIA)

### Appendix B: Preliminary Data
- Existing segmentation performance on pilot dataset
- nnU-Net baseline results
- Niivue platform screenshots

### Appendix C: Ethical Approval
- CharitÃ© IRB approval for DISCHARGE data use
- SCOT-HEART data sharing agreement
- GDPR compliance documentation

---

**Document Version:** 1.0  
**Last Updated:** 2025-12-17  
**Contact:** Flow Project Team  
**Next Action:** Schedule meeting with Prof. Dewey to discuss PI role and refine proposal
